Cargando…
Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
Angiosarcomas are very aggressive, rare malignant tumors that originate from vascular or lymphatic vessels and primarily occur following chemical exposure or radiation therapy. Tumor response to either chemotherapy, radiation, or novel anti-angiogenic therapeutics is very low, and because little is...
Autores principales: | Kurisetty, Vittal, Bryan, Brad A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217701/ https://www.ncbi.nlm.nih.gov/pubmed/25374893 http://dx.doi.org/10.4172/2329-9495.1000102 |
Ejemplares similares
-
MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site
por: Paral, Kristen M., et al.
Publicado: (2015) -
Key Roles for MYC, KIT and RET signaling in secondary angiosarcomas
por: Styring, E, et al.
Publicado: (2014) -
Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma
por: Dickerson, Erin B., et al.
Publicado: (2015) -
The miR-17-92 Cluster and Its Target THBS1 Are Differentially Expressed in Angiosarcomas Dependent on MYC Amplification
por: Italiano, Antoine, et al.
Publicado: (2012) -
Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update
por: Young, Robin J., et al.
Publicado: (2017)